malaria

0 What global health needs is more (value for) money

The Global Fund was, and is, one of the most hopeful, compassionate and impressive things the international community has done in a long time. That’s why it’s being celebrated in and around the grand UN confab this week. That’s why some cheered when Britain announced it would give another $1.6 billion this week, and it’s also why some are clamoring for even more funds – since many millions more are still not reached. But like most things we humans do when we rush in to fix something, it was also seriously flawed.

0 Visualizing progress on 3 Millennium Development Goals (MDGs)

In today’s post, we’ll use Global Burden of Disease Study 2010 (GBD 2010) data to explore how much progress countries have made in two key health MDGs, 4 and 6, the former focused on reducing child mortality and the latter on halting the spread of diseases such as HIV/AIDS and malaria.

0 Plan to produce synthetic anti-malaria drug criticized as “assault on farmers”

A decades’-long struggle to produce a synthetic version of one the world’s favored drugs for treating malaria, artemisinin, was celebrated as a victory for poor people. But now is being criticized as an assault on poor farmers. Global supply of artemisinin, which until now has been produced from harvest of the plant sweet wormwood, has been erratic in both quantity and supply. Hundreds of millions of people fall ill with malaria every year with an estimated 650,000 deaths — mostly in children.

The goal of this project, led by Seattle-based PATH in collaboration with the French drug firm Sanofi, was to supplement the global supply with this synthetic version. PATH officials told me that Sanofi’s ultimate production goal would likely only meet one-third of the global need, but the scientist who developed the synthetic drug said the goal is to totally replace dependence on the natural crop.

0 PATH & Sanofi start major production of synthetic anti-malaria drug

Malaria remains one of the world’s biggest killers and also a massive economic drag on poor countries, poor families. One of our best weapons against this scourge is a drug known as artemisinin, which is harvested from the plant sweet wormwood and, as a crop, is about as predictable as corn or hog futures.A major new initiative to be launched tomorrow in Italy by Seattle-based PATH in collaboration with the French drug maker Sanofi aims to do industrial production of synthetic artemisinin.

1 2 3 4 5 7